Target intelligence / Profile preview

Ran-binding protein 9 (RANBP9)

Target
RANBP9
Molecular classification
Scaffold protein, Adapter protein, Member of CTLH E3 ubiquitin-protein ligase complex, Other (multi-protein complex component)
01

Overview

Ran-binding protein 9 (RANBP9) is an evolutionarily conserved scaffold and adapter protein present in both the nucleus and cytoplasm. It binds RAN (a Ras-superfamily GTPase essential for nuclear transport) and participates in diverse cellular processes, including signal transduction, DNA damage response, and cell adhesion. RANBP9 is a core member of the CTLH E3 ubiquitin-protein ligase complex, mediates protein-protein interactions, and regulates DNA repair—especially homologous recombination—by facilitating ATM kinase activation and chromatin remodeling in response to genotoxic stress. It interacts with many proteins (e.g., MET receptor, androgen receptor, CDK11, and more) and is implicated in both normal development and cancer biology. Deficiency in RANBP9 impairs DNA damage repair mechanisms, heightening cellular sensitivity to genotoxic therapies and causing profound developmental defects in model organisms.

Other names
RanBPMRanBP9BPM-LBPM90Ran-binding protein MRanBP7Ran Binding Protein in the Microtubule Organizing Centernovel centrosomal protein RanBPMran-binding protein 9centrosomal ran-binding proteinran-binding protein M
02

Mechanism of action

Drugs/agents may modulate RanBP9 phosphorylation (e.g., ATM inhibitors like KU-55933 affect nuclear accumulation and DDR activity). Modulation of DNA repair efficiency and sensitivity to genotoxic therapies via ATM-dependent phosphorylation and DDR regulation.

03

Biological functions

Signal transductionDNA damage response (DDR)Homologous recombination-dependent DNA repairCell spreadingActin cytoskeleton rearrangementCell adhesion and migrationUbiquitination and proteasomal degradationChromatin remodelingApoptosis regulation
04

Disease associations

Cancer (notably lung cancer and disease sensitivity to genotoxic stress)Neurodevelopmental diseases (e.g., Masa syndrome, lissencephaly)Other (perinatal lethality, sterility in knockout mice)
05

Safety considerations

Potential role in repair of damaged DNA; targeting may enhance sensitivity to genotoxic agents but could increase risk of unchecked DNA damage or apoptosisRanBP9 deficiency linked to abnormal activation of senescence and apoptosis, early lethality, sterility in model organisms
06

Interacting drugs

cisplatin

2 more in the full profile.

07

Biomarkers

γH2AX (marker of DNA damage/repair, altered in RanBP9-deficient cells)

Beyond the preview

Go deeper on Ran-binding protein 9 (RANBP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ran-binding protein 9 (RANBP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call